TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06694220

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tailored preventive exercises
Description: Players in the experimental group will be asked to perform the tailored preventive program 2-3 times per week for 1 hour for at least 6 weeks preseason which includes warming up for 10 mins, flexibility exercises, strengthening exercises, core and lower body stability and balance exercises and drills all these exercises for 1-4 sets x 10-20 reps and cooling down stretches for the last 10 mins.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional exercises
Description: The players will be warmed up as usual, with jogging and ball-based exercises following FIFA 11+ warming up program which consist of three steps with 15 specific exercises running exercises for 8 mins, starting warming up in pairs; Path consists of 6-10 pairs of parallel cones: (Running Straight Ahead, Running Hip Out, Running Hip In, Running Circling Partner, Running Shoulder Contact, Running Quick Forwards and Backwards, Rep. x2). Strength, plyometric, balance for 10 minutes (The Bench, Sideways Bench, Single-leg Stance, Squats, Jumping Rep. 2x 30 sec each side). Running Exercises for 2 minutes (End of heating): (running across the pitch, running bounding, running plant, and cut. Rep x 2). Techniques need to be performed correctly and with an emphasis on maintaining the correct posture of the body. This exercise program should be done at least twice a week

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional exercises
Description: The players will be warmed up as usual, with jogging and ball-based exercises following FIFA 11+ warming up program which consist of three steps with 15 specific exercises running exercises for 8 mins, starting warming up in pairs; Path consists of 6-10 pairs of parallel cones: (Running Straight Ahead, Running Hip Out, Running Hip In, Running Circling Partner, Running Shoulder Contact, Running Quick Forwards and Backwards, Rep. x2). Strength, plyometric, balance for 10 minutes (The Bench, Sideways Bench, Single-leg Stance, Squats, Jumping Rep. 2x 30 sec each side). Running Exercises for 2 minutes (End of heating): (running across the pitch, running bounding, running plant, and cut. Rep x 2). Techniques need to be performed correctly and with an emphasis on maintaining the correct posture of the body. This exercise program should be done at least twice a week
Study: NCT06690684

Intervention type: BIOLOGICAL
Intervention: Hematological indicators
Description: This project is a retrospective clinical cohort study. STEMI patients undergoing PCI were selected to explore whether hematological indicators such as PIV, SHR, and Lp(a) can improve the accuracy of predicting short-term MACE events in STEMI patients.

Intervention type: BIOLOGICAL
Intervention: Serological indicators in patients with myocardial infarction
Description: This study selected STEMI patients who underwent PCI and collected their hematological indicators to explore the value of PIV, SHR, Lp(a) and other indicators in improving the accuracy of predicting MACE in STEMI patients in the short term.

Intervention type: BIOLOGICAL
Intervention: Levels of biomarkers in blood of patients with acute myocardial infarction
Description: Hemoglobin, neutrophil count, lymphocyte count, monocyte count and platelet count values, N-terminal pro-B type natriuretic peptide (NT-proBNP), peak creatine kinase isoenzymes (CK-MB), peak troponin T levels, total cholesterol (TC), fasting blood glucose (FBG), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and blood urine nitrogen, blood creatinine (Cr) and other indicators
Study: NCT06686199

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: steamed potato
Description: 135 g per day 4-5 times per week for 8 weeks

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: fried potato
Description: 135 g per day 4-5 times per week for 8 weeks
Study: NCT06687200

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Setup with neutral pelvic positioning technique
Description: Setup with neutral pelvic positioning technique (from dosimetry onward and at each session) and daily IGRT (CBCT or MVCT Mega Voltage Computed Tomography)

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard setup
Description: Standard setup (from dosimetry onward and at each session) and daily IGRT (CBCT or MVCT)
Study: NCT05816655

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fulvestrant plus AI plus ribociclib
Description: Fulvestrant + AI + ribociclib +/- GnRH agonist
Study: NCT06688773

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Progressive relaxation exercise
Description: In this study, the relaxation exercises CD, which is a material created by the Turkish Psychological Association, was used. This CD consists of three parts. The first part consists of 10 minutes and this part explains the definition and purpose of deep relaxation exercise and the points to be considered during the exercise. The second part of the CD consists of 30 minutes of verbal explanation of the items of relaxation exercises accompanied by the sound of a stream. The third part consists of 30 minutes and includes only relaxation music.

Intervention type: OTHER
Group type: OTHER
Intervention: Control group: Standart nursing care group
Description: Routine postoperative patient care in the clinic was applied.
Study: NCT06688695

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Neurodevelopmental support
Description: The Intervention for Neurodevelopmental Support in Preterm Infants using Responsive parenting and E-health (INSPIRE) aims to support the infant's neurodevelopment by supporting the parents to develop a responsive approach. The intervention will enhance the infant's social and environmental interactions, focusing on developing both the infant's and parent's strengths, seeking opportunities instead of problems in behaviour, enhancing mutually satisfying interaction and parental empowerment.
Study: NCT06689280

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video-supervised home-based exercise training
Description: 12 weeks of patient-centered video-supervised home-based exercise training that will be kick-started during hospitalization and continued for 12 weeks after discharge, followed by 12 weeks of self-directed maintenance exercise.
Study: NCT04978376

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Time restricted eating
Description: We will compare the effects of time restricted eating alone and combined with resistance exercise of endurance exercise versus a no intervention control group.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Time restricted eating
Description: We will compare the effects of time restricted eating alone and combined with resistance exercise of endurance exercise versus a no intervention control group.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Time restricted eating
Description: We will compare the effects of time restricted eating alone and combined with resistance exercise of endurance exercise versus a no intervention control group.
Study: NCT04965012

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online CBT with MET treatment
Description: The CBT with MET treatment condition will begin with an MET-therapist guided introduction to the program and first module. After this guided introduction, they will have access to the remaining 7 treatment modules and have 6 weeks to complete them. The content of all modules is derived from Cognitive Behavioural Therapy and Motivational Interviewing. Through module engagement, participants will identify goals related to cannabis use, learn strategies to cope with cravings, triggers, and social pressures, and learn to how prevent relapse. Participants will work through modules sequentially.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CBT without MET treatment
Description: The CBT without MET treatment condition will begin with a brief non-MET trained research assistant welcome to the program, and will not include working through the first module together. After this welcome, they will have access to the 8 treatment modules and have 6 weeks to complete them. The content of all modules is derived from Cognitive Behavioural Therapy and Motivational Interviewing. Through module engagement, participants will identify goals related to cannabis use, learn strategies to cope with cravings, triggers, and social pressures, and learn to how prevent relapse. Participants will work through modules sequentially.
Study: NCT05650099

Intervention type: DEVICE
Intervention: One or two dental implants (Biomet3I dental implant system) were placed 10 years ago
Description: All patients were 10 years ago referred to the Department of Oral and Maxillofacial Surgery (University of Groningen, University Medical Hospital) because of missing posterior teeth and were treated with dental implant placement and implant-supported restorations. Patients will have a regular routine control visit (as part of regular follow-up of these patients)
Study: NCT06214949

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Personalized Repetitive Transcranial Magnetic Stimulation
Description: Treatment will consist of 15 sessions over 3-4 weeks. Specifically, the active or sham treatments will be conducted \~5 times a week during the treatment phase of the study. The treatment protocol parameters (stimulus location, frequency, duration, and intensity) will be derived from the PrTMS software algorithm which incorporates clinical inputs from neurocognitive surveys and quantitative EEG analysis. The mechanical parameters will adhere to the recommended PrTMS parameters for pain treatment: figure of 8 coil that produces biphasic stimulatory pulses to the central zone cortex, frontal zone cortex, Broca's area, and frontal pre-cortex areas at a stimulation depth of 2 cm. Treatment parameters will be unique to each participant but will remain within known ranges. The frequency will be between 8 and 13 Hz, at an amplitude of 20-30% (approximately 30-40% of RMT), and about 3200-7200 pulses per session. Since parameters are specific to each participant, treatment settings will vary.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham Personalized Repetitive Transcranial Magnetic Stimulation
Description: Treatment will consist of 15 sessions over the course of 3-4 weeks. More specifically, the active or sham treatments will be conducted roughly 5 times a week during the course of the treatment phase of the study. The TMS system will have three coils, one designated active and the other two unlabeled and identical in appearance, weight, and noises emitted, one of which will be active and one of which will be sham.
Study: NCT06486922

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: StEP OUT
Description: The details of program structure and content will evolve as the study progresses based on feedback from participants, interventionists, and the community advisory board. Initially, we will plan to have 5 formal sessions structured as groups with multiple participants receiving the session simultaneously, primarily via remote videoconference, though sessions may occur individually, based on participant schedule and preference. All sessions are designed to be supportive, educational, and interactive, with opportunities to practice skills and discuss feeding and parenting concerns.
Study: NCT05321797

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic Training
Description: This group will be administered with the cycling exercises in addition to the complete plan of care that is being administered to the control group. The cycling intervention will be performed 3 times per week, for 30 minutes, within a 12-week period

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Physiotherapy
Description: This group will be administered with Conventional Physiotherapy that includes 5 minutes of stretching exercises for quadriceps, hamstrings and gastrocnemius, 5 minutes of trunk control training, 5 minutes walking in the hall with and without the therapist assistance, walker or crutches, and finally 5 minutes of breathing exercises for Relaxation

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Physiotherapy
Description: This group will be administered with Conventional Physiotherapy that includes 5 minutes of stretching exercises for quadriceps, hamstrings and gastrocnemius, 5 minutes of trunk control training, 5 minutes walking in the hall with and without the therapist assistance, walker or crutches, and finally 5 minutes of breathing exercises for Relaxation
Study: NCT04942418

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multicolor hybrid ceramic laminate veneers.
Description: Multi shaded blocks have been recently introduced to the market, due to lack of evidence in clinical performance evaluating marginal adaptation and shade matching of the polychromatic newly introduced blocks comparing their different color gradient. Multicolor hybrid ceramic laminate veneers.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Multicolor fieldspathic ceramic laminate veneers.
Description: the feldspathic ceramic blocks display the highest translucent properties of all ceramic blocks which make them the first choice in the esthetic zone. esthetic and translucency with polychromatic feature and resilience properties.
Study: NCT05217979

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcutaneous pulsed radiofrequency
Description: single treatment with transcutaneous pulsed radiofrequency, for a duration of 15 minutes, at a strength of 800 mA.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: Sham treatment by turning on the device in demo mode. No treatment delivered, but indistinguishable by sound or visual signals or sensations felt by the study participant
Study: NCT05816655

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: AI plus ribociclib
Description: AI + ribociclib +/- GnRH agonist
Study: NCT05748938

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RD14-01
Description: ROR1 Targeted CAR-T cells
Study: NCT06688318

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Intra-articular secretome injection therapy
Description: Intra-articular secretome injection therapy from hypoxic umbilical cord mesenchymal stem cell conditioned media
Study: NCT06688513

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Carealth Phone App
Description: The goal for this study is to assess Carealth app's ability to connect patients to resources to meet patient's identified SDH needs, with the end goal of assessing reduction in 30-day readmission and missed visits by connecting patients to resources to meet their social needs in a way that enables them to receive care earlier or avoid complications.
Study: NCT05089890

Intervention type: DEVICE
Group type: OTHER
Intervention: Sorbact® Compress
Description: Sorbact® technology is a bacteria- and fungi-binding wound contact layer from which Sorbact® Compress has been developed. The patients will be in one of these 3 arms depending on the choice of dressing most suitable for their wounds.~The purpose of the study is not to compare between the devices, but to study each device on its own.

Intervention type: DEVICE
Group type: OTHER
Intervention: Sorbact® Gel Dressing
Description: Sorbact® technology is a bacteria- and fungi-binding wound contact layer from which Sorbact® Gel Dressing has been developed. The patients will be in one of these 3 arms depending on the choice of dressing most suitable for their wounds.~The purpose of the study is not to compare between the devices, but to study each device on its own.

Intervention type: DEVICE
Group type: OTHER
Intervention: Sorbact® Ribbon Gauze
Description: Sorbact® technology is a bacteria- and fungi-binding wound contact layer from which Sorbact® Ribbon Gauze has been developed. The patients will be in one of these 3 arms depending on the choice of dressing most suitable for their wounds.~The purpose of the study is not to compare between the devices, but to study each device on its own.
Study: NCT05274022

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard of Care Physical Therapy Program
Description: Standard of care will follow best practice. The subjects and their physical therapists will be provided with a standardized set of exercises and guidance on what to cover during skilled physical therapy visits. As part of the study, all patients will receive the same exercise program. Exercises will include lower extremity strengthening, balance, and mobility exercises with the use of modalities as needed

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard of Care Physical Therapy Program
Description: Standard of care will follow best practice. The subjects and their physical therapists will be provided with a standardized set of exercises and guidance on what to cover during skilled physical therapy visits. As part of the study, all patients will receive the same exercise program. Exercises will include lower extremity strengthening, balance, and mobility exercises with the use of modalities as needed

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Speed Walking Intervention
Description: The 4-6 week program will consist of a warm up of active stretching. Following the warm up, subjects will perform a 2 minute warm up followed by 1 minute of walking at their fastest comfortable speed followed by 2 minutes of active recovery where they will walk at a speed of their choosing for 4cycles and then a 2 minute cool down. The program will be performed 12 visits over 4-6 weeks.
Study: NCT05963867

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 764532
Description: BI 764532

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 764532
Description: BI 764532

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [89Zr]Zr-BI 764532
Description: \[89Zr\]Zr-BI 764532

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [89Zr]Zr-BI 764532
Description: \[89Zr\]Zr-BI 764532
Study: NCT06688513

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Let's Talk: Sharing information about Family Cancer Risk
Description: An interactive tool that patients can use to learn about how to talk with their family members about the family member's cancer risk
Study: NCT06686459

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: ALL-in-one radiotherapy
Description: ALL-in-one radiotherapy (breast + supraclavicular + internal mammary lymph node drainage area)
Study: NCT06197425

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FOLFIRI cures
Description: (Irinotecan 180 mg/m2, leucovorine 400mg/m2, 5FU bolus 400 mg/m2, 5FU continuous infusion 2400 mg/m2) every 14 days for 6 months or until disease progression on imaging

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trifluridine cures
Description: Trifluridine tipiracil 35 mg/m2 bid during 5 days/w on week 1 and 2 every 4 weeks, for 6 months or until disease progression on imaging

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BIOLOGICAL ASSESSMENT
Description: blood sample ACE markers

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BIOLOGICAL ASSESSMENT
Description: blood sample ACE markers

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: BIOLOGICAL ASSESSMENT
Description: blood sample ACE markers
Study: NCT06686459

Intervention type: RADIATION
Group type: PLACEBO_COMPARATOR
Intervention: IMRT
Description: IMRT (breast + supraclavicular + internal mammary lymph node drainage area)
Study: NCT06197425

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Quality of life questionnaires (QLQ-C30 ; EQ-5D-5L ; GPAQ)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Quality of life questionnaires (QLQ-C30 ; EQ-5D-5L ; GPAQ)
Study: NCT06633042

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Universal BCMA-CD19 CART
Description: 1.0-4.0×10\^6 CAR-T cells/kg
Study: NCT06694610

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: non-pulmonary vein ablation group
Description: In the non-pulmonary vein ablation group, pulmonary vein isolation was not allowed, but the left atrial low-voltage area was treated first, and then the ablation route that terminated the reentry ring was treated.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: only pulmonary vein ablation group
Description: In the group treated with only pulmonary vein ablation route, only potential isolation of pulmonary vein was performed, and bidirectional block was the end point.
Study: NCT06694402

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: focal muscle vibration combined with exercise
Description: The treatment group will receive a 30-minute intervention in each session. Focal muscle vibration will be applied to the anterior and lateral parts of shoulder to give a sensory stimulation while participants are doing eaercise.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: exercise
Description: The control group will receive 30-minute exercise without focal muslce vibration.
Study: NCT06694376

Intervention type: OTHER
Intervention: No intervention
Description: No intervention.
Study: NCT06686368

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: I-DROP MGD
Description: All drops are to be used for 28-30 days, twice daily with assessment done at Day 0, 30 minutes post-installation at day 0, day 7 and day 28/30

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Theloze Duo
Description: All drops are to be used for 28-30 days, twice daily with assessment done at Day 0, 30 minutes post-installation at day 0, day 7 and day 28/30
Study: NCT06197425

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaires
Description: Quality of life questionnaires (QLQ-C30 ; EQ-5D-5L ; GPAQ)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Thoracic-abdomino-pelvic scan or MRI
Description: Thoracic-abdomino-pelvic scan or MRI
Study: NCT06686368

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Systane Complete PF
Description: All drops are to be used for 28-30 days, twice daily with assessment done at Day 0, 30 minutes post-installation at day 0, day 7 and day 28/30
Study: NCT06197425

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Thoracic-abdomino-pelvic scan or MRI
Description: Thoracic-abdomino-pelvic scan or MRI

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Thoracic-abdomino-pelvic scan or MRI
Description: Thoracic-abdomino-pelvic scan or MRI
Study: NCT06686524

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti-CD19 UCAR-T cells
Description: A single infusion of CD19 UCAR-T cells will be administered intravenously after lymphodepletion chemotherapy.